End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.03 CNY | +1.30% |
|
-1.54% | -19.84% |
10/06 | Tecon Biology's Pig Sales Revenue Rises in May | MT |
10/05 | Tecon Biology's April Pig Sales Revenue Fall 9% | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company shows low valuation levels, with an enterprise value at 0.65 times its sales.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.84% | 1.3B | - | ||
-4.73% | 275B | A- | ||
-7.19% | 91.01B | C+ | ||
-12.61% | 39.83B | C+ | ||
-1.77% | 37.97B | B- | ||
-1.28% | 37.6B | B- | ||
-16.19% | 29.99B | B- | ||
-4.72% | 29.05B | A | ||
+6.63% | 23.53B | A- | ||
-15.73% | 20.66B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 002100 Stock
- Ratings TECON BIOLOGY Co.LTD